Consumer Goods & Retail Global On demand · 24-48h

Global Cosmetics and Personal Care Safety and Efficacy Testing Market Strategic Research Report

Global Cosmetics and Personal Care Safety and Efficacy Testi…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Cosmetics and Personal Care Safety and Efficacy Testing Market
$1.27B2025
9.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Clinical Research Services, Cosmetics Testing to Regulation, Allergen Screening, Microbiology Testing, Ingredients Testing, Others

By Application: Cosmetics, Personal Care Products, Sunscreen, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: SGS SA (Switzerland), Intertek Group Plc (UK), Eurofins Scientific SE (Luxembourg), Bureau Veritas SA (France), UL LLC (USA), Centre Testing International (China), PONY Testing Group Co., Ltd. (China), China Certification & Inspection Group (China), Iwase Cosfa Co., Ltd. (Japan), Dermatest GmbH (Germany), Microchem Laboratory (USA), Kirei Testing Labo(Japan)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 102 pages
Market size 2025
$1.27B
Billion USD
Forecast CAGR
9.9%
2025-2032
Forecast 2032
$2.5B
Projected
Regiões
5
Asia Pacific · Latin America · MEA · Europe · North America

Visão geral

Scope of the Report

The global Cosmetics and Personal Care Safety and Efficacy Testing market size is predicted to grow from US$ 1,272 million in 2025 to US$ 2,459 million in 2032; it is expected to grow at a CAGR of 9.9% from 2026 to 2032.

Cosmetics and Personal Care Safety and Efficacy Testing is a comprehensive scientific evaluation framework designed to assess the safety, stability, and functional performance of cosmetics, skincare, and broader personal care products through toxicological studies, physicochemical analysis, microbiological testing, and human efficacy trials in compliance with global regulatory requirements. Compared with traditional cosmetic-only evaluation systems, it extends coverage to a wider range of personal care applications, ensuring product safety and performance validation across diverse usage scenarios. Its advantages include high technical barriers, stringent regulatory compliance requirements, and the ability to enhance brand credibility and market competitiveness through scientifically validated evidence. In 2025, the industry’s average gross margin was approximately 35%. Upstream, the core inputs include high-precision analytical instruments, laboratory consumables, and chemical reagents, with representative suppliers such as Thermo Fisher Scientific, Agilent Technologies, Waters Corporation, and Merck providing essential testing infrastructure and materials. The midstream focuses on physicochemical testing, microbiological analysis, toxicological safety assessment, and human efficacy trials, forming standardized and authoritative compliance reports. Downstream mainly covers cosmetics, sunscreen products, and personal care products, with representative customers including L'Oréal, Procter & Gamble, Estée Lauder, Unilever, and Shanghai Jahwa.

Cosmetics and Personal Care Safety and Efficacy Testing is increasingly shaped by stricter global regulatory frameworks, rising consumer demand for clinically validated claims, and continuous innovation in skincare and personal care formulations. As brands shift toward functional differentiation such as anti-aging, skin barrier repair, and microbiome balance, demand for robust toxicological and human efficacy validation is intensifying. At the same time, expansion into sensitive-skin and sustainable formulations increases testing complexity and scope. Service providers capable of integrating regulatory compliance, multi-dimensional testing, and global standardization are better positioned to capture value, particularly as multinational brands consolidate testing workflows to improve efficiency and consistency.

This report presents a comprehensive overview of the global Cosmetics and Personal Care Safety and Efficacy Testing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Clinical Research Services
  • Cosmetics Testing to Regulation
  • Allergen Screening
  • Microbiology Testing
  • Ingredients Testing
  • Others

Segment by Sample Size

  • n<50
  • 50≤n≤100
  • Others

Segment by Customer

  • Brand Owner Testing
  • OEM/ODM Manufacturer Testing
  • Ingredient Supplier Testing

Segment by Application

  • Cosmetics
  • Personal Care Products
  • Sunscreen
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cosmetics and Personal Care Safety and Efficacy Testing market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Cosmetics, Personal Care Products, Sunscreen evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Cosmetics and Personal Care Safety and Efficacy Testing Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.27B
2025
Forecast
$2.5B
2032
CAGR
9.9%
2025–2032
Regiões
5
global
Key companies
SGS SA (Switzerland)Intertek Group Plc (UK)Eurofins Scientific SE (Luxembourg)Bureau Veritas SA (France)UL LLC (USA)Centre Testing International (China)PONY Testing Group Co.Ltd. (China)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Clinical Research ServicesCosmetics Testing to RegulationAllergen ScreeningMicrobiology TestingIngredients TestingOthers
By Application
CosmeticsPersonal Care ProductsSunscreenOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Clinical Research Services
  • 3.1.3 Cosmetics Testing to Regulation
  • 3.1.4 Allergen Screening
  • 3.1.5 Microbiology Testing
  • 3.1.6 Ingredients Testing
  • 3.1.7 Others
  • 3.1.8 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Cosmetics
  • 4.1.3 Personal Care Products
  • 4.1.4 Sunscreen
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 SGS SA (Switzerland)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Intertek Group Plc (UK)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Eurofins Scientific SE (Luxembourg)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Bureau Veritas SA (France)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 UL LLC (USA)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Centre Testing International (China)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 PONY Testing Group Co., Ltd. (China)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 China Certification & Inspection Group (China)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Iwase Cosfa Co., Ltd. (Japan)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Dermatest GmbH (Germany)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Microchem Laboratory (USA)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Kirei Testing Labo(Japan)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Cosmetics and Personal Care Safety and Efficacy Testing market?
The global Cosmetics and Personal Care Safety and Efficacy Testing market is estimated at US$ 1.27 billion in 2025 (base year) and is projected to reach US$ 2.46 billion by 2032.
What is the forecast CAGR for the Cosmetics and Personal Care Safety and Efficacy Testing market?
The market is expected to grow at a CAGR of 9.9% from 2026 to 2032, expanding from US$ 1.27 billion in 2025 to US$ 2.46 billion in 2032, roughly 1.9 times its base-year value.
What is Cosmetics and Personal Care Safety and Efficacy Testing?
Cosmetics and Personal Care Safety and Efficacy Testing is a comprehensive scientific evaluation framework designed to assess the safety, stability, and functional performance of cosmetics, skincare, and broader personal care products through toxicological studies, physicochemical analysis, microbiological testing, and human efficacy trials in compliance with global regulatory requirements.
How is the Cosmetics and Personal Care Safety and Efficacy Testing market segmented by type?
By type, the market is segmented into Clinical Research Services, Cosmetics Testing to Regulation, Allergen Screening, Microbiology Testing, Ingredients Testing and Others.
What are the key applications of Cosmetics and Personal Care Safety and Efficacy Testing?
Key applications covered include Cosmetics, Personal Care Products, Sunscreen and Others.
Which companies are profiled in the Cosmetics and Personal Care Safety and Efficacy Testing market report?
Key players profiled include SGS SA (Switzerland), Intertek Group Plc (UK), Eurofins Scientific SE (Luxembourg), Bureau Veritas SA (France), UL LLC (USA), Centre Testing International (China), PONY Testing Group Co., Ltd. (China) and China Certification & Inspection Group (China), among 12 companies covered in total.
What geographies does the Cosmetics and Personal Care Safety and Efficacy Testing market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the main risks and barriers in the Cosmetics and Personal Care Safety and Efficacy Testing market?
Its advantages include high technical barriers, stringent regulatory compliance requirements, and the ability to enhance brand credibility and market competitiveness through scientifically validated evidence.
Who should buy the Cosmetics and Personal Care Safety and Efficacy Testing market report?
The report is intended for manufacturers and solution providers, distributors and end users in Cosmetics, Personal Care Products and Sunscreen, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cosmetics and Personal Care Safety and Efficacy Testing market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.